Target Name: Bone morphogenetic protein (BMP)
NCBI ID: P40670
Review Report on Bone morphogenetic protein (BMP) Target / Biomarker Content of Review Report on Bone morphogenetic protein (BMP) Target / Biomarker
Bone morphogenetic protein (BMP)
Other Name(s): Bone morphogenetic protein | BMP

BMP: A Potential Drug Target and Biomarker for Various Diseases

Bone Morphogenetic Protein (BMP) is a protein that plays a vital role in the development and maintenance of bone tissue. It is a transmembrane glycoprotein that is expressed in a variety of tissues, including bone, fat, and connective tissue. BMP is involved in the regulation of cellular processes that are essential for bone growth and development, including cell proliferation, differentiation, and angiogenesis.

BMP has been identified as a potential drug target and a biomarker for a variety of diseases, including cancer, obesity, and neurodegenerative disorders. Its role in these diseases has led to a growing interest in the study of BMP and its potential applications as a therapeutic agent.

One of the key functions of BMP is its ability to stimulate cell proliferation and differentiation. BMP has been shown to induce the growth and differentiation of osteogenic stem cells ( osteogens) into functional osteocytes, which are responsible for maintaining bone tissue. This process is critical for the development and maintenance of bone tissue, and it is thought to be a potential therapeutic approach for the treatment of bone-related diseases.

BMP has also been shown to play a role in the regulation of cell survival and apoptosis. It has been shown to induce cell apoptosis in response to various stimuli, including exposure to chemotherapy drugs or radiation. This process is important for the regulation of cellular aging and death, and it may be a potential therapeutic approach for the treatment of diseases associated with cellular dysfunction.

In addition to its role in cell proliferation and differentiation, BMP has also been shown to play a role in the regulation of angiogenesis. It has been shown to induce the growth and development of blood vessels, and this process is important for the delivery of oxygen and nutrients to bone tissue. This may be a potential therapeutic approach for the treatment of bone-related diseases associated with poor blood supply.

BMP has also been shown to play a role in the regulation of immune responses. It has been shown to influence the activity of immune cells, including T cells and macrophages. This process is important for the regulation of immune responses, and it may be a potential therapeutic approach for the treatment of autoimmune diseases.

In conclusion, BMP is a protein that plays a vital role in the development and maintenance of bone tissue. Its ability to stimulate cell proliferation and differentiation, regulate cell survival and apoptosis, and influence immune responses makes it a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of BMP in these diseases and to develop effective therapeutic approaches based on its properties.

Protein Name: Bone Morphogenetic Protein (BMP) (nonspecified Subtype)

The "Bone morphogenetic protein (BMP) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Bone morphogenetic protein (BMP) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP | BRI3P1 | BRI3P2 | BRICD5 | BRINP1 | BRINP2 | BRINP3 | BRIP1 | BRISC complex | BRIX1 | BRK1 | BRME1 | BRMS1 | BRMS1L | Bromodomain adjacent to zinc finger domain protein | Bromodomain-containing protein | BROX | BRPF1 | BRPF3 | BRS3 | BRSK1 | BRSK2 | BRWD1 | BRWD1 intronic transcript 2 (non-protein coding) | BRWD1-AS2 | BRWD3 | BSCL2 | BSDC1 | BSG | BSN | BSN-DT | BSND | BSPH1 | BSPRY | BST1 | BST2 | BSX | BTAF1 | BTBD1 | BTBD10 | BTBD16 | BTBD17 | BTBD18 | BTBD19 | BTBD2 | BTBD3